Based on responses to the questionnaire, you are initially pre-qualified for treatment with Tirzepatide!
After enrollment, you will be sent additional onboarding instructions for our secure patient portal called Healthie where the rest of this process will take place.
Tirzepatide is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. Tirzepatide is not approved for weight loss. This is an under-the-skin, once a week injection.
Tirzepatide – Mechanism of Action
Tirzepatide is both a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It selectively binds to and activates the GIP and GLP-1 receptors, the targets for native GIP and GLP-1 hormones. GIP and GIP-1 are hormones that are primarily released from the body’s small intestine that enhances the release of insulin following the consumption of food. Both of these hormones are known as incretins, with tirzepatide belonging to a class of drugs known as incretin mimetics. Tirzepatide works by directly activating GIP and GLP-1 pathways to help regulate blood sugar.
Tirzepatide – Adverse Reactions
The most common side effects of tirzepatide include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Tirzepatide. Please discuss with your physician the contraindications and other warnings and precautions before starting tirzepatide.